- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Janssen admitted a Crohn’s awareness campaign sent to UK gastroenterologists promoted ustekinumab for an unlicensed indication and was…
PV consultant alleged off-label exacerbation-risk promotion for Ultibro. Panel found breaches for a FLAME “business card” and unclear…
Lilly challenged a Levemir advertorial in Pulse. PMCPA found the “Weight advantages with Levemir” section misleading/ambiguous and inconsistent…
Servier rep’s proactive call rate exceeded Code limits and biscuits/snacks were used to gain access. Panel found breaches…
A pharmacist alleged Servier reused a Coversyl ad previously ruled misleading. The Panel found the ad had been…
A medical representative alleged AstraZeneca meetings were visible to the public and that surgery meetings were fund-raising with…
Ferring agreed in inter-company dialogue to withdraw a Cortiment leavepiece but it was still used at a conference…
Anonymous complaint about an unsolicited MSL email to an NHS address during COVID-19. Panel found the email was…
RCGP Overdiagnosis Group challenged a Pfizer/BMS Eliquis email promoting AF pulse checks at flu clinics for over-65s, alleging…
LEO discovered four cross-border transfers of value involving three UK patient organisations. Three 2019 payments were disclosed late…
One real case. One key lesson. Every week — free.